Mangalam Drugs & Organics P/B Ratio
Mangalam Drugs & Organics (MANGALAM) P/B ratio is 0.47 (Low), book value per share ₹64.38 vs Healthcare average P/B of -0.29 — Very Low - Significant discount to book value, potential distress or value opportunity. Review MANGALAM P/E ratio to evaluate earnings-based valuation against sector peers.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
MANGALAM P/B Ratio — Valuation Insights & Book Value Analysis
Mangalam Drugs & Organics price-to-book ratio interpretation, valuation status and historical context — current P/B 0.47 (Low). View MANGALAM 52-week high low for the annual high/low range and current price position.
- Stock appears undervalued with PB of 0.47, trading below book value
- Trading below book value - potential value opportunity or financial distress signal
- Current PB is 32.9% below historical average
- Trading at premium to sector average PB of -0.29
Mangalam Drugs & Organics P/B Ratio Historical Trend
MANGALAM annual price-to-book ratio — 3 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. For live price, earnings yield and the full fundamental profile, see MANGALAM stock price BSE.
MANGALAM Historical P/B Ratio — Book Value Per Share & Year-End Price
Mangalam Drugs & Organics annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 0.44 | ₹64.38 | ₹28.13 | ₹103 | Low |
| 2025 | 0.3 | ₹93.12 | ₹27.51 | ₹149 | Low |
| 2024 | 1.36 | ₹85.0 | ₹115.48 | ₹136 | Moderate |
MANGALAM vs Healthcare Peers — P/B Ratio Comparison
Mangalam Drugs & Organics P/B 0.47 vs Healthcare average -0.29, median 0.61 — range -16.4–1.11.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -16.4 | ₹20 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Parmax Pharma | PARMAX | -4.18 | ₹29 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.23 | ₹73 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.79 | ₹126 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.56 | ₹50 | Low |